Recursion Pharmaceuticals, Inc. (RXRX)
Uses AI and robotics to discover new drugs faster than traditional methods.
$2.99-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-47.4%
The outlook
RXRX is trading near its 52-week lows, well below both its 50- and 200-day moving averages. Analyst price targets average around 143% above the current price, though coverage sentiment leans bearish overall. The stock sits deeply in the lower end of its yearly range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +143% vs current price
Analyst price target
~12-month · 6 analysts$7.25average target+142.9% vs now
Now $2.99
Low $4.00High $10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.58B
52-wk high
$7.18
52-wk low
$2.77
50-day avg
$3.29
200-day avg
$3.96
Trailing P/E
—